摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[[2-[[4-[N'-[4-[[(3S)-4-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propylamino]-4-oxo-3-[[4-[3-(trifluoromethyl)diazirin-3-yl]benzoyl]amino]butanoyl]amino]butyl]carbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid | 1373169-91-5

中文名称
——
中文别名
——
英文名称
3-[[2-[[4-[N'-[4-[[(3S)-4-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propylamino]-4-oxo-3-[[4-[3-(trifluoromethyl)diazirin-3-yl]benzoyl]amino]butanoyl]amino]butyl]carbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
英文别名
——
3-[[2-[[4-[N'-[4-[[(3S)-4-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propylamino]-4-oxo-3-[[4-[3-(trifluoromethyl)diazirin-3-yl]benzoyl]amino]butanoyl]amino]butyl]carbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid化学式
CAS
1373169-91-5
化学式
C62H78F3N15O11S
mdl
——
分子量
1298.46
InChiKey
FWPJLUJFQUSPKW-QZMVMWQSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    92
  • 可旋转键数:
    39
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    374
  • 氢给体数:
    9
  • 氢受体数:
    21

反应信息

  • 作为产物:
    描述:
    C64H82F3N15O11S 在 、 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 17.0h, 以48%的产率得到3-[[2-[[4-[N'-[4-[[(3S)-4-[3-[2-[2-[3-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]propoxy]ethoxy]ethoxy]propylamino]-4-oxo-3-[[4-[3-(trifluoromethyl)diazirin-3-yl]benzoyl]amino]butanoyl]amino]butyl]carbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
    参考文献:
    名称:
    Dabigatran and Dabigatran Ethyl Ester: Potent Inhibitors of Ribosyldihydronicotinamide Dehydrogenase (NQO2)
    摘要:
    Recent studies have revealed that compounds believed to be highly selective frequently address multiple target proteins. We investigated the protein interaction profile of the widely prescribed thrombin inhibitor dabigatran (1), resulting in the identification and subsequent characterization of an additional target enzyme. Our findings are based on an unbiased functional proteomics approach called capture compound mass spectrometry (CCMS) and were confirmed by independent biological assays. 1 was shown to specifically bind ribosyldihydronicotinamide dehydrogenase (NQO2), a detoxification oxidoreductase. Molecular dockings predicted and biological experiments confirmed that dabigatran ethyl ester (2) inhibits NQO2 even more effectively than the parent 1 itself. Our data show that 1 and 2 are inhibitors of NQO2, thereby revealing a possible new aspect in the mode of action of 1. We present a workflow employing chemical proteomics, molecular modeling, and functional assays by which a compound's protein-interaction profile can be determined and used to tune the binding affinity.
    DOI:
    10.1021/jm3001339
点击查看最新优质反应信息

文献信息

  • Dabigatran and Dabigatran Ethyl Ester: Potent Inhibitors of Ribosyldihydronicotinamide Dehydrogenase (NQO2)
    作者:Simon Michaelis、Anett Marais、Anna K. Schrey、Olivia Y. Graebner、Cornelia Schaudt、Michael Sefkow、Friedrich Kroll、Mathias Dreger、Mirko Glinski、Hubert Koester、Rainer Metternich、Jenny J. Fischer
    DOI:10.1021/jm3001339
    日期:2012.4.26
    Recent studies have revealed that compounds believed to be highly selective frequently address multiple target proteins. We investigated the protein interaction profile of the widely prescribed thrombin inhibitor dabigatran (1), resulting in the identification and subsequent characterization of an additional target enzyme. Our findings are based on an unbiased functional proteomics approach called capture compound mass spectrometry (CCMS) and were confirmed by independent biological assays. 1 was shown to specifically bind ribosyldihydronicotinamide dehydrogenase (NQO2), a detoxification oxidoreductase. Molecular dockings predicted and biological experiments confirmed that dabigatran ethyl ester (2) inhibits NQO2 even more effectively than the parent 1 itself. Our data show that 1 and 2 are inhibitors of NQO2, thereby revealing a possible new aspect in the mode of action of 1. We present a workflow employing chemical proteomics, molecular modeling, and functional assays by which a compound's protein-interaction profile can be determined and used to tune the binding affinity.
查看更多

同类化合物

顺式-(-)-1,3-二苄基六氢-2-氧代-1H-噻吩并[3,4-d]咪唑-4-戊酸 荧光素醋酸 芴甲氧羰基-谷氨酰胺酸(生物素基-聚乙二醇) 脲氨基酸氧羰基肼-d-生物素 联锡酰氨基己酰-6-氨基己酸N-羟基琥珀酰亚胺酯 磺基琥珀生物素 磺基琥珀生物素 磺基琥珀亚氨基-6-(生物素胺)乙酸 碳杂浅蓝菌素 甲基硫代磺酸2-{N2-[N6-(4-叠氮基-2,3,5,6-四氟苯甲酰基)-6-氨基己酰基]-N6-(6-生物素氨基己酰基)-L-赖氨酰氨基}乙基 甲基硫代磺酸2-[Nα-苯甲酰基苯甲酰氨基-N6-(6-生物素氨基己酰基)-L-赖氨酰胺基]乙基 甲基硫代磺酸2-[N2-(4-叠氮基-2,3,5,6-四氟苯甲酰基)-N6-(6-生物素氨基己酰基)-L-赖氨酰]乙基酯 生物胞素酰胺基乙基甲烷硫代磺酸酯三氟乙酸盐 生物素酰肼 生物素酰基-4-氨基丁酸 生物素杂质27 生物素基酰胺基乙基-3-(3-碘-4-羟基苯基)丙酰胺 生物素基酰胺基乙基-3-(3,5-二碘-4-羟基苯基)丙酰胺 生物素基酪氨酰胺 生物素基-6-氨基喹啉 生物素化-epsilon-氨基己酸-N-羟基丁二酰亚胺活化酯 生物素五聚乙二醇乙基叠氮 生物素二酸 生物素XX酰肼 生物素4-氨基苯甲酸钠盐 生物素-普萘洛尔类似物 生物素-二聚乙二醇 生物素-乙二胺氢溴酸盐 生物素-七聚乙二醇-胺 生物素-七聚乙二醇-叠氮化物 生物素-PEG6-羟基 生物素-PEG4-胺 生物素-PEG3-羧酸 生物素-PEG3-琥珀酰亚胺酯 生物素-PEG2-C6-叠氮 生物素-PEG2-C4-炔 生物素-PEG12-羧酸 生物素-PEG12-琥珀酰亚胺酯 生物素-PEG12-四氟苯酚酯 生物素-N-羟基磺酸基琥珀酰亚胺酯 生物素 尿囊素生物素盐 光生物素 五氟苯酚生物素酯 二亚乙基三胺五乙酸Α,Ω-双(生物胞素酰胺) 丙酸,3-[(3-氨基-2-吡啶基)硫代]-(9CI) [3aS-(3aalpha,4beta,6aalpha)]-六氢-2-氧代-1,3-二(苯基甲基)-1H-噻吩并[3,4-d]咪唑-4-戊酸苯甲酯 [3AS-(3AALPHA,4BETA,6AALPHA)]-N-[3-[2-[2-(3-氨基丙氧基)乙氧基]乙氧基]丙基]六氢-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺单(三氟乙酸)盐 WSDBCO-BIOTIN,DBCO-SULFO-LINK-BIOTIN,磺基-二苯并环辛炔-生物素共轭物 O-(2-氨基乙基)-O'-[2-(生物素基氨基)乙基]八聚乙二醇